Prognostic value of liver fibrosis and steatosis biomarkers in type-2 diabetes and dyslipidaemia

Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - a prospective cohort study with paired transient elastography examinations

(2014) G. L.-H. Wong et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C

(2014) J. Boursier et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: “APRI c’est fini ?”

(2014) Hugo Perazzo et al.   Clinics and Research in Hepatology and Gastroenterology

Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus

(2013) V. de Lédinghen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets

(2013) Z. M. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2013) Paul Angulo et al.   GASTROENTEROLOGY

Association Between High-Normal Levels of Alanine Aminotransferase and Risk Factors for Atherogenesis

(2013) M. Shadab Siddiqui et al.   GASTROENTEROLOGY

NAFLD fibrosis score: A prognostic predictor for mortality and liver complications among NAFLD patients

(2013) Sombat Treeprasertsuk   WORLD JOURNAL OF GASTROENTEROLOGY

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Nonalcoholic fatty liver disease is associated with coronary artery calcification

(2012) Donghee Kim et al.   HEPATOLOGY

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

The Framingham risk score and heart disease in nonalcoholic fatty liver disease

(2012) Sombat Treeprasertsuk et al.   LIVER INTERNATIONAL

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data

(2012) Thierry Poynard et al.   PLoS One

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

(2011) Thierry Poynard et al.   BMC GASTROENTEROLOGY

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

(2011) R. M. Williamson et al.   DIABETES CARE

Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease

(2011) W. Nseir et al.   DIGESTIVE DISEASES AND SCIENCES

Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C

(2011) Julien Vergniol et al.   GASTROENTEROLOGY

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

(2011) V. W.-S. Wong et al.   GUT

Fatty liver index and mortality: The cremona study in the 15th year of follow-up

(2011) Giliola Calori et al.   HEPATOLOGY

Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study

(2010) Leon A Adams et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies

(2010) Thierry Poynard et al.   ANTIVIRAL THERAPY

Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?

(2010) Billur Canbakan et al.   Biomarkers in Medicine

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Alcoholic liver disease

(2009) Robert S. O'Shea et al.   HEPATOLOGY

Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study

(2008) Winston Dunn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Screening for Liver Fibrosis by Using a Noninvasive Biomarker in Patients With Diabetes

(2008) S JACQUEMINET et al.   Clinical Gastroenterology and Hepatology

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

(2008) Philippe Halfon et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

(2008) Sylvie Naveau et al.   HEPATOLOGY

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY